Klimas J, Small W, Ahamad K, Cullen W, Mead A, Rieb L, Wood E, McNeil R Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors Addict Sci Clin Pract, 2017. PubMed

Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015 J Int AIDS Soc, 2017. PubMed

Cheng T, DeBeck K Between a rock and a hard place: prescription opioid restrictions in the time of fentanyl and other street drug adulterants Can J Public Health, 2017. PubMed

Hayashi K, Ti L, Ayutthaya PPN, Suwannawong P, Kaplan K, Small W, Kerr T Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study Harm Reduct J, 2017. PubMed

Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boué F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort Addiction, 2017. PubMed

Panagiotoglou D, Krebs E, Min JE, Olding M, Ahamad K, Ti L, Montaner JSG, Nosyk B Initiating HCV treatment with direct acting agents in opioid agonist treatment: when to start for people co-infected with HIV? Int J Drug Policy, 2017. PubMed

Mah A, Hull MW, DeBeck K, Milloy MJ, Dobrer S, Nosova E, Wood E, Kerr T, Hayashi K Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals Int J Drug Policy, 2017. PubMed

Gonzalez-Serna A, Ajaykumar A, Gadawski I, Muñoz-Fernández MA, Hayashi K, Harrigan P, Côté H Rapid decrease in peripheral blood mononucleated cell telomere length after HIV seroconversion, but not HCV seroconversion J Acquir Immune Defic Syndr, 2017. PubMed

Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Milloy MJ, Kerr T, Montaner J, Wood E Awareness, possession, and use of take-home naloxone among illicit drug users, Vancouver, British Columbia, 2014-2015 Public Health Rep, 2017. Link

Socías ME, Nosova E, Kerr T, Hayashi K, Harrigan PR, Shoveller J, Montaner J, Milloy MJ Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting Clin Infect Dis, 2017. PubMed

Filter Publications

  • Year

    -
  • Reset filter